A case of atypical absence seizures induced by leuprolide acetate

Pediatric Neurology

Volumn 23, Issue 3, 2000, Pages 266-268

  Akaboshi, Shinjiro ^a   Takeshita, Kenzo ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPRORELIN;

ABSENCE; ADOLESCENT; ARTICLE; BRAIN FOURTH VENTRICLE; BRAIN INJURY; CASE REPORT; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDULLOBLASTOMA; PRIORITY JOURNAL; SEIZURE;

ADOLESCENT; ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN DAMAGE, CHRONIC; CASE REPORT; CEREBELLAR NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; FEMALE; HUMAN; LEUPROLIDE; LONG-TERM CARE; MEDULLOBLASTOMA;

EID: 0033776888     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(00)00181-8     Document Type: Article

References (17)

1. Plosker G.L., Brogden R.N. Leuprorelin A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders. Drugs. 48:1994;930-967.
2. Thomas B.C., Stanhope R., Leiper A.D. Gonadotropin releasing hormone analogue and growth hormone therapy in precocious and premature puberty following cranial irradiation for acute lymphoblastic leukemia. Horm Res. 39:1993;25-29.
3. Carel J.-C., Lahlou N., Guazzarotti L., et al. Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group. Eur J Endcrinol. 132:1995;699-704.
4. Minagawa K., Sueoka H. Seizure exacerbation by the use of leuprorelin acetate for treatment of central precocious puberty in a female patient with symptomatic localized-related epilepsy. (in Japanese) No To Hattatsu. 31:1999;466-468.
5. Mazzei T., Mini E., Rizzo M., Periti P. Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. J Int Med Res. 18:(Suppl 1):1990;42-56.
6. Okada H., Doken Y., Ogawa Y. Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate. J Pharm Sci. 85:1996;1044-1048.
7. Joels M. Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol. 18:1997;2-48.
8. Julien R.M., Fowler G.W., Danielson M.G. The effects of antiepileptic drugs on estrogen-induced electrographic spike-wave discharge. J Pharmacol Exp Ther. 193:1975;647-656.
9. Logothetis J., Harner R., Morrell F., Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology. 9:1959;352-360.
10. Rosenfield R.L., Garibaldi L.R., Moll G.W. Jr, Watson A.C., Burstein S. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endcrinol Metab. 63:1986;1386-1389.
11. Monroe S.E., Henzl M.R., Martin M.C., et al. Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist Significance of time in cycle. Fertil Steril. 43:1985;361-368.
12. Kletzky O.A., Davajan V., Mishell D.R. Jr. The effect of gonadotropin-releasing hormone on ovarian estradiol secretion. Am J Obstet Gynecol. 142:1982;427-431.
13. Bauer J., Wildt L., Flügel D., Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy A study in ten patients. J Neurol. 239:1992;284-286.
14. Pfaff D.W., Schwanzel-Fukuda M., Parhar I.S., Lauber D.W., McCarthy M.M., Kow L.-M. GnRH neurons and other cellular and molecular mechanisms for simple mammalian reproductive behaviors. Recent Prog Horm Res. 49:1994;1-25.
15. Jennes L., Conn P.M. Gonadotropin-releasing hormone and its receptors in rat brain. Front Neuroendcrinol. 15:1994;51-77.
16. Marchetti B., Gallo F., Farinella Z., et al. Luteinizing hormone-releasing hormone is a primary signaling molecule in the neuroimmune network. Ann NY Acad Sci. 840:1998;205-248.
17. Lewis D., Ikeda S.R. Inhibition of M-type K+ and N-type Ca2+ channels by the human gonadotropin-releasing-hormone receptor heterologously expressed in adult neurons. Neuroendocrinol. 66:1997;235-245.